Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys

被引:25
|
作者
Marti-Pastor, Marc [1 ,2 ,3 ]
Pont, Angels [1 ,2 ]
Avila, Monica [1 ,2 ,4 ]
Garin, Olatz [1 ,2 ,4 ]
Vilagut, Gemma [1 ,2 ,4 ]
Forero, Carlos G. [1 ,2 ,4 ]
Pardo, Yolanda [1 ,2 ,3 ]
Tresserras, Ricard [4 ,5 ]
Medina-Bustos, Antonia [5 ]
Garcia-Codina, Oriol [5 ]
Cabases, Juan [6 ]
Rajmil, Luis [1 ,2 ,7 ]
Alonso, Jordi [1 ,2 ,4 ]
Ferrer, Montse [1 ,2 ,3 ]
机构
[1] IMIM Hosp Mar Med Res Inst, Hlth Serv Res Grp, Doctor Aiguader 88, Barcelona 08003, Spain
[2] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain
[3] Univ Autonoma Barcelona, Barcelona, Spain
[4] Univ Pompeu Fabra, Barcelona, Spain
[5] Dept Salut Gen Catalunya, Direccio Gen Planificacio Salut, Barcelona, Spain
[6] Univ Publ Navarra, Pamplona, Spain
[7] Agcy Healthcare Qual & Assessment Catalonia AQuAS, Barcelona, Spain
来源
POPULATION HEALTH METRICS | 2018年 / 16卷
关键词
Quality of life; Health survey; Validity and reliability; Perceived health; QUALITY-OF-LIFE; CANCER-PATIENTS; OUTCOME MEASURES; 5-LEVEL VERSION; UNITED-KINGDOM; STANDARD EQ-5D; PATIENT GROUPS; RESPONSIVENESS; INSTRUMENTS; VALIDITY;
D O I
10.1186/s12963-018-0170-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The EQ-5D has been frequently used in national health surveys. This study is a head-to-head comparison to assess how expanding the number of levels from three (EQ-5D-3L) to five in the new EQ-5D-5L version has improved its distribution, discriminatory power, and validity in the general population. Methods: A representative sample (N = 7554) from the Catalan Health Interview Survey 2011-2012, aged >= 18, answered both EQ-5D versions, and we evaluated the response redistribution and inconsistencies between them. To assess validity of this redistribution, we calculated the mean of the Visual Analogue Scale (VAS), which measures perceived health. The discriminatory power was examined with Shannon Indices, calculated for each dimension separately. Spanish preference value sets were applied to obtain utility indices, examining their distribution with statistics of central tendency and dispersion. We estimated the proportion of individuals reporting the best health state in EQ-5D-5L and EQ-5D-3L within groups of specific chronic conditions and their VAS mean. Results: A very small reduction in the percentage of individuals with the best health state was observed, from 61.8% in EQ-5D-3L to 60.8% in EQ-5D-5L. In contrast, a large proportion of individuals reporting extreme problems in the 3 L version moved to severe problems (level 4) in the 5 L version, particularly for pain/discomfort (75.5%) and anxiety/depression (66.4%). The average proportion of inconsistencies was 0.9%. The pattern of the perceived health VAS mean confirmed the hypothesis established a priori, supporting the validity of the observed redistribution. Shannon index showed that absolute informativity was higher in the 5 L version for all dimensions. The means (SD) of the Spanish EQ5D- 3L and EQ-5D-5L indices were 0.87 (0.25) and 0.89 (0.22). The proportion of individuals with the best health state within each specific chronic condition was very similar, regardless of the EQ-5D version (<= 30% in half of the 28 chronic conditions). Conclusion: Although the proportion of individuals with the best possible health state is still very high, our findings support that the increase of levels provided by the EQ-5D-5L contributed to the validity and discriminatory power of this new version to measure health in general population, as in the national health surveys.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Population norms for the EQ-5D-3L and EQ-5D-5L in Romania
    Elena Olariu
    Raluca Caplescu
    Luke Vale
    Ileana Gabriela Niculescu-Aron
    Yemi Oluboyede
    Marian Sorin Paveliu
    Health and Quality of Life Outcomes, 21
  • [22] THE COMPARISON OF CHINA EQ-5D-3L AND EQ-5D-5L VALUE SETS APPLIED IN GENERAL POPULATION
    Zhou, T.
    Ma, A.
    VALUE IN HEALTH, 2018, 21 : S109 - S109
  • [23] Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B
    Jia, Y. X.
    Cui, F. Q.
    Li, L.
    Zhang, D. L.
    Zhang, G. M.
    Wang, F. Z.
    Gong, X. H.
    Zheng, H.
    Wu, Z. H.
    Miao, N.
    Sun, X. J.
    Zhang, L.
    Lv, J. J.
    Yang, F.
    QUALITY OF LIFE RESEARCH, 2014, 23 (08) : 2355 - 2363
  • [24] A Head-to-Head Comparison of EQ-HWB and EQ-5D-5L in Patients, Carers, and General Public in China
    Long, Chen
    Mao, Zhuxin
    Yang, Zhihao
    VALUE IN HEALTH, 2024, 27 (07) : 848 - 856
  • [25] Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B
    Y. X. Jia
    F. Q. Cui
    L. Li
    D. L. Zhang
    G. M Zhang
    F. Z. Wang
    X. H. Gong
    H. Zheng
    Z. H. Wu
    N. Miao
    X. J. Sun
    L. Zhang
    J. J. Lv
    F. Yang
    Quality of Life Research, 2014, 23 : 2355 - 2363
  • [26] REFERENCE EQ-5D-3L AND EQ-5D-5L DATA FROM THE ITALIAN GENERAL POPULATION
    Scalone, L.
    Cortesi, P. A.
    Mantovani, L. G.
    Ciampichini, R.
    Cesana, G.
    VALUE IN HEALTH, 2014, 17 (07) : A514 - A515
  • [27] A head-to-head comparison of the adult EQ-5D-5L and youth EQ-5D-Y-5L in adolescents with idiopathic scoliosis
    Bonsel, Joshua M.
    Peeters, Charles M. M.
    Reijman, Max
    Dings, Tim
    Rutges, Joost P. H. J.
    Kempen, Diederik H. R.
    Verhaar, Jan A. N.
    Bonsel, Gouke J.
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2025, 9 (01)
  • [28] Head-to-Head Comparison of EQ‐5D‐3L and EQ‐5D‐5L Health Values
    Anna Selivanova
    Erik Buskens
    Paul F. M. Krabbe
    PharmacoEconomics, 2018, 36 : 715 - 725
  • [29] A head-to-head comparison of the EQ-5D-3L index scores derived from the two EQ-5D-3L value sets for China
    Ruo-Yu Zhang
    Wei Wang
    Hui-Jun Zhou
    Jian-Wei Xuan
    Nan Luo
    Pei Wang
    Health and Quality of Life Outcomes, 20
  • [30] A head-to-head comparison of the EQ-5D-3L index scores derived from the two EQ-5D-3L value sets for China
    Zhang, Ruo-Yu
    Wang, Wei
    Zhou, Hui-Jun
    Xuan, Jian-Wei
    Luo, Nan
    Wang, Pei
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2022, 20 (01)